We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current FBRX market cap is 30.91M. The company's latest EPS is USD -21.5304 and P/E is -0.06.
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.86M | -15.89M | -6.38M | -7.8M | -12.82M |
| Net Income | -6.75M | -15.65M | -5.87M | -7.42M | -12.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36k | 0 | 0 | 0 | 0 |
| Operating Income | -61.51M | -46.28M | -21.49M | -13.9M | -32.49M |
| Net Income | -63.52M | -46.49M | -21.71M | -13.88M | -31.48M |
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.71M | 31.18M | 38.98M | 32.02M | 26.08M |
| Total Liabilities | 3.76M | 6.3M | 3.67M | 3.33M | 9.12M |
| Total Equity | 32.95M | 24.88M | 35.31M | 28.69M | 16.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.16M | 61.24M | 43.31M | 42M | 38.98M |
| Total Liabilities | 17.31M | 2.26M | 1.76M | 3.18M | 3.67M |
| Total Equity | 10.85M | 58.98M | 41.55M | 38.82M | 35.31M |
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.2M | -10.68M | -28.71M | -6.67M | -12.6M |
| Investing | N/A | -9.97M | 47k | -6k | -6k |
| Financing | 6k | -18k | 24.68M | -8k | -18k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -59.24M | -18.42M | -16.68M | -8.19M | -28.71M |
| Investing | 42.32M | 3.58M | N/A | N/A | 47k |
| Financing | -14.91M | 66.67M | -44k | 7.24M | 24.68M |
| Market Cap | 30.91M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.05 |
| Price to Book Ratio | 0.05 |
| Dividend Yield | - |
| Shares Outstanding | 1.46M |
| Average Volume (1 week) | 97.39k |
| Average Volume (1 Month) | 92.35k |
| 52 Week Change | 2.63% |
| 52 Week High | 28.68 |
| 52 Week Low | 4.11 |
| Spread (Intraday) | 3.54 (14.81%) |
| Company Name | Forte Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.fortebiorx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
